(Q42475036)

1 November 2017

title

Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome (English)

1 reference

1 November 2017

4

Khamashta MA

1 reference

1 November 2017

Lakasing L

1

1 reference

1 November 2017

Campa JS

series ordinal

2

1 reference

1 November 2017

Poston R

series ordinal

3

1 reference

1 November 2017

Poston L

series ordinal

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

American Journal of Obstetrics and Gynecology

1 November 2017

published in

1 reference

1 November 2017

volume

181

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

180-189

1 reference

The antiphospholipid syndrome: ten years on.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Adverse pregnancy outcome in the antiphospholipid syndrome: focus for future research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Fetal stem vessel endothelial changes in placentae from normal and abnormal pregnancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Microvascular perturbations in human allografts: analogies in preeclamptic placentae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970457-6

10.1016/S0002-9378(99)70457-6

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference